133 related articles for article (PubMed ID: 7703282)
1. A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.
Stewart AK; Dubé ID; Kamel-Reid S; Keating A
Hum Gene Ther; 1995 Jan; 6(1):107-19. PubMed ID: 7703282
[No Abstract] [Full Text] [Related]
2. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.
Dunbar CE; Nienhuis AW; Stewart FM; Quesenberry P; O'Shaughnessy J; Cowan K; Cottler-Fox M; Leitman S; Goodman S; Sorrentino BP
Hum Gene Ther; 1993 Apr; 4(2):205-22. PubMed ID: 8098622
[No Abstract] [Full Text] [Related]
3. Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma.
Björkstrand B; Gahrton G; Dilber MS; Ljungman P; Smith CI; Xanthopoulos KG
Hum Gene Ther; 1994 Oct; 5(10):1279-86. PubMed ID: 7531504
[No Abstract] [Full Text] [Related]
4. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
O'Shaughnessy JA; Cowan KH; Wilson W; Bryant G; Goldspiel B; Gress R; Nienhuis AW; Dunbar C; Sorrentino B; Stewart FM
Hum Gene Ther; 1993 Jun; 4(3):331-54. PubMed ID: 8338880
[No Abstract] [Full Text] [Related]
6. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
7. Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation.
Heslop HE; Brenner MK; Krance RA; Bowman L; Cunningham JM; Richardson S; Alexander B; Heideman R; Boyett JM; Srivastava DK; Marcus SG; Berenson R; Heimfeld S; Brown S
Hum Gene Ther; 1996 Mar; 7(5):655-67. PubMed ID: 8845391
[No Abstract] [Full Text] [Related]
8. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
9. Autologous and allogeneic transplants for multiple myeloma.
Barlogie B; Jagannath S; Vesole D; Tricot G
Semin Hematol; 1995 Jan; 32(1):31-44. PubMed ID: 7878476
[No Abstract] [Full Text] [Related]
10. Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Gobbi M; Tazzari PL; Cavo M; Tassi C; Grimaldi M; Meloni G; Di Nucci G; Vignetti M; Bolognesi A; Stirpe F
Bone Marrow Transplant; 1991; 7 Suppl 2():30. PubMed ID: 1878704
[No Abstract] [Full Text] [Related]
11. Multiple myeloma. New approaches to therapy.
Dunbar CE; Nienhuis AW
JAMA; 1993 May; 269(18):2412-6. PubMed ID: 7683062
[No Abstract] [Full Text] [Related]
12. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach.
Horvath N; Hahn U; Joshua D; Dyson P; Gibson J; Stevens J; Rawling T; Barrow L; Brown R; Stephens S; Gower G; Norman J; Mills B; To LB
Intern Med J; 2004 Apr; 34(4):167-75. PubMed ID: 15086696
[TBL] [Abstract][Full Text] [Related]
14. Marrow transplantation for myeloma.
Fermand JP; Brouet JC
Annu Rev Med; 1995; 46():299-307. PubMed ID: 7598466
[TBL] [Abstract][Full Text] [Related]
15. Autologous stem-cell transplantation in multiple myeloma.
Gahrton G
Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
[TBL] [Abstract][Full Text] [Related]
16. Tandem bone marrow transplantation in multiple myeloma.
Musto P
N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074004
[No Abstract] [Full Text] [Related]
17. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
18. Human MDR gene transfer in patients with advanced cancer.
Hesdorffer C; Antman K; Bank A; Fetell M; Mears G; Begg M
Hum Gene Ther; 1994 Sep; 5(9):1151-60. PubMed ID: 7833373
[No Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation for multiple myeloma.
Jagannath S; Barlogie B
Hematol Oncol Clin North Am; 1992 Apr; 6(2):437-49. PubMed ID: 1582984
[TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for multiple myeloma].
Kosugi H
Rinsho Ketsueki; 2015 Mar; 56(3):279-88. PubMed ID: 25876781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
